A Study of Imlunestrant (LY3484356) in Female Participants With Impaired Liver Function

NCT05440344 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

27

Enrollment

INDUSTRY

Sponsor class

Conditions

Hepatic Insufficiency
Healthy

Interventions

DRUG: Imlunestrant

Sponsor

Eli Lilly and Company